Robin Markowitz

Robin Markowitz is CEO of Lymphoma Canada. 

Lymphoma Canada urges governments to speed up access to approved cancer drugs

• Strides in cancer research have increased survival rates and provided a better quality of life for patients under treatment. But getting the best treatment

Opinion | BY ROBIN MARKOWITZ | April 23, 2018

Lymphoma Canada urges governments to speed up access to approved cancer drugs

Opinion | BY ROBIN MARKOWITZ | April 23, 2018

• Strides in cancer research have increased survival rates and provided a better quality of life for patients under treatment. But getting the best treatment

Lymphoma Canada urges governments to speed up access to approved cancer drugs

Opinion | BY ROBIN MARKOWITZ | April 23, 2018

• Strides in cancer research have increased survival rates and provided a better quality of life for patients under treatment. But getting the best treatment

Lymphoma Canada urges governments to speed up access to approved cancer drugs

• Strides in cancer research have increased survival rates and provided a better quality of life for patients under treatment. But getting the best treatment

Opinion | BY ROBIN MARKOWITZ | April 23, 2018

Lymphoma Canada urges governments to speed up access to approved cancer drugs

Opinion | BY ROBIN MARKOWITZ | April 23, 2018

• Strides in cancer research have increased survival rates and provided a better quality of life for patients under treatment. But getting the best treatment

Lymphoma Canada urges governments to speed up access to approved cancer drugs

Opinion | BY ROBIN MARKOWITZ | April 23, 2018

• Strides in cancer research have increased survival rates and provided a better quality of life for patients under treatment. But getting the best treatment

More Stories